Epoch Pharmaceuticals, VimRx deal

The companies will develop their technology in the areas of viral and retroviral therapies and cancer. As part of the deal, the companies agreed to settle a dispute between Epoch and VMRX's German subsidiary, formerly called Ribonetics, which VMRX purchased in May. ...